Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance. | Case Rep Neurol Med | 2026 | 42078791 | PubTator, text mining | PubMed |
| Successful treatment with eculizumab in refractory myasthenia gravis with both anti-AChR and anti-LRP4 antibodies: two case reports. | J Neuroimmunol | 2026 | 42035597 | PubTator, text mining | PubMed |
| Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet | 2026 | 42030965 | PubTator, text mining | PubMed |
| Agrin as a Stable Biomarker for Muscle Strength Decline in Elderly Sarcopenic Patients Associated with Neuromuscular Junction Dysfunction. | Rejuvenation Res | 2026 | 41969047 | PubTator, text mining | PubMed |
| Molecular structure of the third immunoglobulin domain (Ig3) of human Muscle-Specific kinase (MuSK). | J Struct Biol | 2026 | 41956176 | PubTator, text mining | PubMed |
| Hidden diagnoses among patients with double seronegative myasthenia gravis. | Front Neurol | 2026 | 41940306 | PubTator, text mining | PubMed |
| A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation. | Int J Circumpolar Health | 2026 | 41919672 | PubTator, text mining | PubMed |
| Ophthalmoplegia Caused by Non-Aneurysm Neurovascular Conflict: Clinical Cases of Eight Patients. | Rev Neurol | 2026 | 41914338 | PubTator, text mining | PubMed |
| Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia Gravis. | Eur J Immunol | 2026 | 41906599 | PubTator, text mining | PubMed |
| Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia. | Infect Drug Resist | 2026 | 41809936 | PubTator, text mining | PubMed |
| Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. | Biologics | 2026 | 41808843 | PubTator, text mining | PubMed |
| Clinical and electrophysiological characteristics of myasthenia gravis patients with concomitant type 2 diabetes mellitus. | Front Neurol | 2026 | 41798820 | PubTator, text mining | PubMed |
| The gut as a central hub for multi-organ crosstalk in aging. | Cell Mol Life Sci | 2026 | 41787017 | PubTator, text mining | PubMed |
| Early-Onset Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Following First-Cycle Pembrolizumab: Diagnostic Challenges and Management Strategies. | Cureus | 2026 | 41777983 | PubTator, text mining | PubMed |
| Progress in the Treatment of Refractory Myasthenia Gravis. | Rev Neurol | 2026 | 41761996 | PubTator, text mining | PubMed |
| The Relationship Between Immune Semaphorins and Myasthenia Gravis. | Brain Behav | 2026 | 41761565 | PubTator, text mining | PubMed |
| Structure and Function of Ocular Proteoglycans: Essential Proteins for Vision. | Int J Mol Sci | 2026 | 41752079 | PubTator, text mining | PubMed |
| Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity. | Front Immunol | 2026 | 41743715 | PubTator, text mining | PubMed |
| Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study. | Front Immunol | 2026 | 41737228 | PubTator, text mining | PubMed |
| Simultaneous Diagnosis of Myasthenia Gravis and Neurosyphilis, With Symptoms Improving After Neurosyphilis Treatment: A Case Report. | Cureus | 2026 | 41732618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=2